Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Drugs in R&D
|
March 27, 2021
A Review on the Efficacy and Safety of Oral Semaglutide
Stephanie Niman, Jennifer Hardy, Rebecca F Goldfaden, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
March 14, 2020
A Review of the Efficacy and Tolerability of Bempedoic Acid in the Treatment of Hypercholesterolemia
Stephanie Niman, Khyatiben Rana, Jessica Reid, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
February 12, 2020
Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease Prevention
Jessica Reid, Khyatiben Rana, Stephanie Niman, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
October 2, 2019
A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data
Khyatiben Rana, Jessica Reid, Joshua N Rosenwasser, et al.
Clinical Diabetes : a Publication of the American Diabetes Association
|
April 27, 2017
Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin
Mark L Warren, Louis B Chaykin, Serge Jabbour, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
September 14, 2022
Imeglimin in type 2 diabetes
Jessica Huston, Hannah Schaffner, Logan Langley, et al.
Diabetes Care
|
January 11, 2008
Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis?
Mae Sheikh-Ali, Brad S Karon, Ananda Basu, et al.
Life Sciences
|
June 26, 2012
Inhibition of apolipoprotein A-I gene by the aryl hydrocarbon receptor: a potential mechanism for smoking-associated hypoalphalipoproteinemia
Emad Naem, Rosalyn Alcalde, Margaret Gladysz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 24, 2024
Insulin icodec: A novel once-weekly treatment for diabetes
Hannah Schaffner, Jordyn Wiener, Amanda DeLuca, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
May 15, 2023
A Critical Review of Icosapent Ethyl in Cardiovascular Risk Reduction
Jessica Huston, Hannah Schaffner, Alyssa Cox, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Drugs in R&D
|
March 27, 2021
A Review on the Efficacy and Safety of Oral Semaglutide
Stephanie Niman, Jennifer Hardy, Rebecca F Goldfaden, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
March 14, 2020
A Review of the Efficacy and Tolerability of Bempedoic Acid in the Treatment of Hypercholesterolemia
Stephanie Niman, Khyatiben Rana, Jessica Reid, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
February 12, 2020
Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease Prevention
Jessica Reid, Khyatiben Rana, Stephanie Niman, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
October 2, 2019
A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data
Khyatiben Rana, Jessica Reid, Joshua N Rosenwasser, et al.
Clinical Diabetes : a Publication of the American Diabetes Association
|
April 27, 2017
Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin
Mark L Warren, Louis B Chaykin, Serge Jabbour, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
September 14, 2022
Imeglimin in type 2 diabetes
Jessica Huston, Hannah Schaffner, Logan Langley, et al.
Diabetes Care
|
January 11, 2008
Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis?
Mae Sheikh-Ali, Brad S Karon, Ananda Basu, et al.
Life Sciences
|
June 26, 2012
Inhibition of apolipoprotein A-I gene by the aryl hydrocarbon receptor: a potential mechanism for smoking-associated hypoalphalipoproteinemia
Emad Naem, Rosalyn Alcalde, Margaret Gladysz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 24, 2024
Insulin icodec: A novel once-weekly treatment for diabetes
Hannah Schaffner, Jordyn Wiener, Amanda DeLuca, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
May 15, 2023
A Critical Review of Icosapent Ethyl in Cardiovascular Risk Reduction
Jessica Huston, Hannah Schaffner, Alyssa Cox, et al.
Page
of 2